annual CFF:
$514.32M+$422.45M(+459.83%)Summary
- As of today (September 16, 2025), PRAX annual cash flow from financing activities is $514.32 million, with the most recent change of +$422.45 million (+459.83%) on December 31, 2024.
- During the last 3 years, PRAX annual CFF has risen by +$406.74 million (+378.06%).
- PRAX annual CFF is now at all-time high.
Performance
PRAX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$28.32M-$25.65M(-47.52%)Summary
- As of today (September 16, 2025), PRAX quarterly cash flow from financing activities is $28.32 million, with the most recent change of -$25.65 million (-47.52%) on June 30, 2025.
- Over the past year, PRAX quarterly CFF has dropped by -$187.77 million (-86.89%).
- PRAX quarterly CFF is now -86.89% below its all-time high of $216.09 million, reached on June 30, 2024.
Performance
PRAX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$198.04M-$187.77M(-48.67%)Summary
- As of today (September 16, 2025), PRAX TTM cash flow from financing activities is $198.04 million, with the most recent change of -$187.77 million (-48.67%) on June 30, 2025.
- Over the past year, PRAX TTM CFF has dropped by -$204.15 million (-50.76%).
- PRAX TTM CFF is now -61.50% below its all-time high of $514.32 million, reached on December 31, 2024.
Performance
PRAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PRAX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +459.8% | -86.9% | -50.8% |
| 3 y3 years | +378.1% | +10000.0% | +2126.1% |
| 5 y5 years | +751.7% | +21.7% | +356.4% |
PRAX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4814.7% | -86.9% | >+9999.0% | -61.5% | +2126.1% |
| 5 y | 5-year | at high | +4814.7% | -86.9% | >+9999.0% | -61.5% | +2126.1% |
| alltime | all time | at high | +4814.7% | -86.9% | +193.9% | -61.5% | +2126.1% |
PRAX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $28.32M(-47.5%) | $198.04M(-48.7%) |
| Mar 2025 | - | $53.97M(-52.9%) | $385.80M(-25.0%) |
| Dec 2024 | $514.32M(+459.8%) | $114.60M(+9865.4%) | $514.32M(+27.4%) |
| Sep 2024 | - | $1.15M(-99.5%) | $403.59M(+0.3%) |
| Jun 2024 | - | $216.09M(+18.4%) | $402.18M(+57.4%) |
| Mar 2024 | - | $182.49M(+4621.5%) | $255.52M(+181.2%) |
| Dec 2023 | $91.87M(+777.9%) | $3.87M(-1621.7%) | $90.87M(-1.4%) |
| Sep 2023 | - | -$254.00K(-100.4%) | $92.16M(-3.6%) |
| Jun 2023 | - | $69.42M(+289.4%) | $95.55M(+263.3%) |
| Mar 2023 | - | $17.83M(+245.9%) | $26.30M(+172.4%) |
| Dec 2022 | $10.46M | $5.15M(+64.2%) | $9.65M(-19.7%) |
| Sep 2022 | - | $3.14M(+1663.5%) | $12.02M(+35.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $178.00K(-85.0%) | $8.90M(-91.8%) |
| Mar 2022 | - | $1.18M(-84.3%) | $107.92M(+1.0%) |
| Dec 2021 | $107.59M(-64.7%) | $7.52M(>+9900.0%) | $106.82M(-64.5%) |
| Sep 2021 | - | $19.00K(-100.0%) | $301.19M(-26.5%) |
| Jun 2021 | - | $99.20M(>+9900.0%) | $409.90M(+22.7%) |
| Mar 2021 | - | $91.00K(-100.0%) | $333.98M(+10.0%) |
| Dec 2020 | $304.42M(+404.1%) | $201.88M(+85.7%) | $303.72M(+99.7%) |
| Sep 2020 | - | $108.73M(+367.2%) | $152.12M(+250.6%) |
| Jun 2020 | - | $23.27M(-177.1%) | $43.39M(+115.7%) |
| Mar 2020 | - | -$30.17M(-160.0%) | $20.11M(-60.0%) |
| Dec 2019 | $60.39M(+59.7%) | $50.28M | $50.28M |
| Dec 2018 | $37.80M | - | - |
FAQ
- What is Praxis Precision Medicines, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. annual CFF year-on-year change?
- What is Praxis Precision Medicines, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. quarterly CFF year-on-year change?
- What is Praxis Precision Medicines, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. TTM CFF year-on-year change?
What is Praxis Precision Medicines, Inc. annual cash flow from financing activities?
The current annual CFF of PRAX is $514.32M
What is the all time high annual CFF for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high annual cash flow from financing activities is $514.32M
What is Praxis Precision Medicines, Inc. annual CFF year-on-year change?
Over the past year, PRAX annual cash flow from financing activities has changed by +$422.45M (+459.83%)
What is Praxis Precision Medicines, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of PRAX is $28.32M
What is the all time high quarterly CFF for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high quarterly cash flow from financing activities is $216.09M
What is Praxis Precision Medicines, Inc. quarterly CFF year-on-year change?
Over the past year, PRAX quarterly cash flow from financing activities has changed by -$187.77M (-86.89%)
What is Praxis Precision Medicines, Inc. TTM cash flow from financing activities?
The current TTM CFF of PRAX is $198.04M
What is the all time high TTM CFF for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high TTM cash flow from financing activities is $514.32M
What is Praxis Precision Medicines, Inc. TTM CFF year-on-year change?
Over the past year, PRAX TTM cash flow from financing activities has changed by -$204.15M (-50.76%)